ImmunoPrecise Antibodies's market cap is currently ―. The company's EPS TTM is $-0.419; its P/E ratio is -2.91; ImmunoPrecise Antibodies is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23
Income Statement	-
Total Revenue	C$ 6.22M	C$ 6.15M	C$ 5.69M	C$ 5.62M	C$ 5.17M
Gross Profit	C$ 3.20M	C$ 2.95M	C$ 2.79M	C$ 3.34M	C$ 2.96M
EBIT	C$ -3.45M	C$ -2.58M	C$ -3.83M	C$ -5.94M	C$ -4.59M
EBITDA	C$ -2.14M	C$ -1.23M	C$ -2.33M	C$ -3.96M	C$ -2.91M
Net Income Common Stockholders	C$ -2.94M	C$ -2.62M	C$ -3.56M	C$ -5.13M	C$ -4.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 6.20M	C$ 6.02M	C$ 6.73M	C$ 8.28M	C$ 11.32M
Total Assets	C$ 78.69M	C$ 75.61M	C$ 76.58M	C$ 77.81M	C$ 82.44M
Total Debt	C$ 14.39M	C$ 9.57M	C$ 9.81M	C$ 7.27M	C$ 7.47M
Net Debt	C$ 8.19M	C$ 3.56M	C$ 3.09M	C$ -1.01M	C$ -3.85M
Total Liabilities	C$ 28.87M	C$ 23.58M	C$ 22.74M	C$ 20.01M	C$ 21.36M
Stockholders Equity	C$ 49.82M	C$ 52.03M	C$ 53.84M	C$ 57.80M	C$ 61.08M
Cash Flow	-
Free Cash Flow	C$ -501.00K	C$ -534.00K	-	C$ -2.70M	C$ -18.63M
Operating Cash Flow	C$ -666.00K	C$ -235.00K	C$ -702.00K	C$ -2.23M	C$ -17.60M
Investing Cash Flow	C$ 57.00K	C$ -312.00K	C$ -197.00K	C$ -444.00K	C$ -1.52M
Financing Cash Flow	C$ 613.00K	C$ -310.00K	C$ -405.00K	C$ -381.00K	C$ -240.00K

Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

Income Statement >

ImmunoPrecise Antibodies Debt to Assets

Balance Sheet >

ImmunoPrecise Antibodies Cash Flow

Cash Flow >

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing